Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Dennis

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
Cancer Research|December 1, 1993
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopyP A Philip, C H Thompson, J Carmichael, et al.
British Journal of Cancer|September 1, 1993
A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancerE G de Vries, J A Gietema, P Workman, et al.
British Journal of Cancer|September 1, 1999
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. CRC Phase I/II CommitteeC J Twelves, C Gardner, A Flavin, et al.
Nature|September 3, 2025
Dynamic fibroblast-immune interactions shape recovery after brain injuryNathan A Ewing-Crystal, Nicholas M Mroz, Amara Larpthaveesarp, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
Cancer Research|December 1, 1993
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopyP A Philip, C H Thompson, J Carmichael, et al.
British Journal of Cancer|September 1, 1993
A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancerE G de Vries, J A Gietema, P Workman, et al.
British Journal of Cancer|September 1, 1999
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. CRC Phase I/II CommitteeC J Twelves, C Gardner, A Flavin, et al.
Nature|September 3, 2025
Dynamic fibroblast-immune interactions shape recovery after brain injuryNathan A Ewing-Crystal, Nicholas M Mroz, Amara Larpthaveesarp, et al.
Pageof 3